Evan Rosenbaum

19PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 04, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

|Feb 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

|Dec 01, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar

|Sep 05, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.

Benjamin A Nacev, Martina Bradic, Hyung Jun Woo

|Jul 22, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Ciara M Kelly, Martina Bradic, Sara Saunds

|Jun 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma.

Sujana Movva, Kenneth Seier, Martina Bradic

Pageof 4

Frequent Collaborators

12 joint publications

Sandra P D'Angelo

12 joint publications

William D Tap

11 joint publications

Ciara M Kelly

10 joint publications

Jason E Chan